Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corteva Inc. Common Stock (CTVA) vs Synopsys, Inc. (SNPS) Price & Performance

Corteva Inc. Common StockTrade
Synopsys, Inc.Trade

Price performance (Past 24H)

Key statistics

Corteva Inc. Common Stock vs Synopsys, Inc. — how do they compare? Corteva Inc. Common Stock trades at $13.36 (market cap $9.17B), while Synopsys, Inc. trades at $509.02 (market cap $95.39B). The key difference: Synopsys, Inc. is far larger — about 10.4× Corteva Inc. Common Stock's market cap, and Corteva Inc. Common Stock pays a 5.24% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Synopsys, Inc. for 71 Days on average.

CTVASNPS
Market Cap
$9.17B$95.39B
Volume
35,183,4713,374,903
Sector
Basic MaterialsTechnology
52-Week High
$90.51$534.56
52-Week Low
$11.92$367.70
Typical Hold Time
0 Days71 Days
Enterprise Value
$11.68B$102.62B
Dividend Yield
5.24%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Corteva Inc. Common Stock

No Aura AI signal available yet.

Synopsys, Inc.

Synopsys (SNPS) trades at $502.67, down 0.49% on the day, amid a bullish technical trend and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent news highlights AI-driven partnerships with OpenAI and Amazon, boosting growth prospects. Valuation ratios are elevated, with a P/E of 86.87, reflecting high growth expectations. Analyst sentiment is overwhelmingly positive, with a consensus price target of $572.54.

The outlook for SNPS is favorable, driven by AI integration and strategic acquisitions, but risks include high valuation sensitivity and competitive pressures. Revenue growth and margin expansion from new deals present opportunities, though investors should monitor execution risks and market volatility. The stock's proximity to key resistance levels suggests potential for near-term consolidation or breakout.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTVA
100% Buy0% Sell
Avg holding period · 0 Days
SNPS
63% Buy37% Sell
Avg holding period · 71 Days

Top news

Latest headlines on both assets

About Corteva Inc. Common Stock

Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.

Read more on CTVA →

About Synopsys, Inc.

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Read more on SNPS →